In this Episode, Dr Rachel Giles talks about the following studies presented at the ERS International Virtual Congress 2020 (7-9 Sept):
- McGarvey L, et al. The P2X3 receptor antagonist gefapixant benefits chronic cough.
- Blasi S, et al. COVID-19: Long term respiratory impact.
- Al Chikhanie Y, et al. Early rehab after COVID-19 recommended.
- Wechsler, et al. LIBERTY ASTHMA TRAVERSE trial.
- Kaasgaard M, et al. Sing-a-Lung: Group singing for COPD.
- White E, et al. Changes in biomarkers with nintedanib plus sildenafil.
Posted on
Previous Article
« Mohs surgery may not boost survival over standard excision of melanomas on trunk, extremities Next Article
Stereotactic radiotherapy a win in patients with painful spinal metastases »
« Mohs surgery may not boost survival over standard excision of melanomas on trunk, extremities Next Article
Stereotactic radiotherapy a win in patients with painful spinal metastases »
Table of Contents: ERS 2020
Featured articles
COVID-19 and the Lung
COVID-19 infections: Bronchoscopy provides additional diagnostic certainty
COVID-19 vaccines: An ongoing race
COVID-19: What is the risk of reinfection?
COVID-19 App: The Dutch experience
Secondary pulmonary fibrosis: a possible long-term effect of severe COVID-19
COVID-19 survivors benefit from structured follow-up
Early pulmonary rehabilitation post-COVID-19 aids recovery
Asthma – What's New
Mild asthma: A fundamental change in management
Dupilumab shows long-term efficacy in asthma patients
Severe asthma: Oral corticosteroids maintenance therapy associated with toxicity
First-in-class tyrosine kinase inhibitor shows promise in severe asthma
Predicting individual effectiveness of biologics in severe asthma
IL-5 antagonist showed efficacy in chronic rhinosinusitis with nasal polyps
Treatment according to genotype: The future of asthma therapy?
COPD – The Beat Goes On
The role of chronic symptoms as early biomarkers of COPD development
Urgent call for studies in COPD patients aged 40-60 years
Nasal high-flow therapy: a novel treatment option for hypercapnic COPD patients
Exacerbation history is a reliable predictor of future exacerbations
Singing training effective as physical rehabilitation in COPD
Current prediction tools underestimate exacerbation risk of severe COPD patients
Exercise and Sleep: From Impaired Function to New Therapeutic Strategies
CPAP withdrawal has negative consequences for sleep apnoea patients
Physical activity improves AHI in sleep apnoea patients
The Tobacco Epidemic: From Vaping to Cannabis
Poly-use of nicotine products and cannabis: a deadly combination
E-cigarettes: A source of chronic lung inflammation
Social smoking: Do not underestimate the risks
Chronic Cough – State of the Art
LEAD study shows multiple phenotypes in many chronic cough patients
First-in-class P2X3 receptor antagonist shows promise for chronic cough treatment
Lung Cancer Detection
Lung cancer screening: Most patients not eligible 1-2 years prior to diagnosis
Distinct changes in lung microbiome precede clinical diagnosis of lung cancer
Best of Posters
Smartphone-based cough detection helpful in predicting asthma deterioration
Reduced lung function associated with cognitive decline in the elderly
Longer hospital stay and fewer transplants for frail ILD patients
© 2023 Medicom Medical Publishers. All rights reserved. Terms and Conditions | Privacy Policy